{"ModuleTitle": "Company Description", "CompanyName": "Nektar Therapeutics", "Symbol": "NKTR", "Address": "455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, California, 94158, United States of America", "Phone": "4154825300", "Industry": "Major Pharmaceuticals", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "Nektar Therapeutics is a research-based biopharmaceutical company focused on\r\ndiscovering and developing innovative medicines in areas of high unmet medical\r\nneed. Our research and development pipeline of new investigational drugs\r\nincludes potential therapies for cancer and autoimmune disease. We leverage our\r\nproprietary and proven chemistry platform to discover and design new drug\r\ncandidates. These drug candidates utilize our advanced polymer conjugate\r\ntechnology platforms, which are designed to enable the development of new\r\nmolecular entities that target known mechanisms of action. We continue to make\r\nsignificant investments in building and advancing our pipeline of proprietary\r\ndrug candidates as we believe that this is the best strategy to build long-term\r\nstockholder value. We refer to our drug candidates where we retain at least U.S.\r\ncommercial rights as \"proprietary programs,\" and refer to our other drug\r\ncandidate programs where we have licensed U.S.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f02%2f28%2f0000906709-20-000004.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Gilbert M. Labrucherie", "title": "Senior VP, Chief Operating & Financial Officer"}, {"name": "Howard W. Robin", "title": "President, Chief Executive Officer & Director"}, {"name": "Jonathan Zalevsky", "title": "Chief Research & Development Officer"}], "Number_of_employees": [], "Subsidiaries": ["NO INFO"]}